MAURILLO, LUCA
MAURILLO, LUCA
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
- Evolution of transcriptomic profiles in relapsed inv(16) acute myeloid leukemia T2 - LEUKEMIA RESEARCH
2024 Travaglini, S; Silvestrini, G; Attardi, E; Fanciulli, M; Scalera, S; Antonelli, S; Maurillo, L; Palmieri, R; Divona, M; Ciuffreda, L; Savi, A; Paterno, G; Ottone, T; Barbieri, C; Maciejewski, Jp; Gurnari, C; Ciliberto, G; Voso, Mt
- Is There a Better Therapeutic Time Window from Diagnosis to Treatment for Elderly Acute Myeloid Leukemia Patients Receiving Hypomethylating Agents? T2 - MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
2024 Molica, M; Maurillo, L; Rossi, M; Breccia, M; Mazzone, C; De Fabritiis, P; Perrone, S
- Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial T2 - BLOOD ADVANCES CP - 49th National Congress of the Italian-Society-of-Hematology (SIE)
2024 Venditti, A; Piciocchi, A; Candoni, A; Arena, V; Palmieri, R; Filì, C; Carella, Am; Calafiore, V; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Curti, A; Luppi, M; Ingrosso, C; Martelli, Mp; Cuneo, A; Albano, F; Mulè, A; Tafuri, A; Cudillo, L; Tieghi, A; Fracchiolla, Ns; Capelli, D; Trisolini, Sm; Alati, C; La Sala, E; Maurillo, L; Del Principe, Mi; Irno Consalvo, Ma; Divona, Md; Ottone, T; Cerretti, R; Sconocchia, G; Voso, Mt; Fazi, P; Vignetti, M; Buccisano, F
5-AZACYTIDINE FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA: RESULTS IN 45 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM
2008 Musto, P; Maurillo, L; Spagnoli, A; Genuardi, M; Lunghi, M; Di Renzo, N; Mele, G; Levis, A; D'Arco, A; Gozzini, A; Petrini, M; Mianulli, M; Sanpaolo, G; Santagostino, A; Pietrantuono, G; D'Auria, E; Ferrero, D; Gaidano, G; Ferrara, E; Santini, V; Leone, G; Bosi, A; Venditti, A
5-AZACYTIDINE FOR THE TREATMENT OF INTERMEDIATE-2/HIGH IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS IN 83 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM
2008 Maurillo, L; Spagnoli, A; Gozzini, A; Cecconi, N; D'Argenio, M; Lunghi, M; Rocco, S; Palumbo, G; Rivellini, E; Genuardi, M; Sibilla, S; Ferrara, F; Mele, G; Filardi, N; Sanpaolo, G; Specchia, G; Tonso, A; Santagostino, A; Voso, M T; Balleari, E; Cassibba, V; Della Cioppa, P; Mazzone, C; Oliva, E; Ciuffreda, L; Russo, D; Galimberti, S; Villani, O; D'Auria, F; Di Renzo, N; D'Arco, A M
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia
2022 Paterno, G; Guarnera, L; Palmieri, R; Del Prete, V; Bonanni, F; Buzzatti, E; Moretti, F; Casciani, P; Savi, A; Di Cave, D; Maurillo, L; Buccisano, F; Venditti, A; Del Principe, Mi
A complex clinical presentation of ultra-high risk acute promyelocytic leukemia: A case report and insights on management T2 - CURRENT RESEARCH IN TRANSLATIONAL MEDICINE
2025 De Marchi, L; Paterno, G; Taka, K; Giannì, L; Colafranceschi, G; Ottone, T; Rizzo, M; Divona, M; Palmieri, R; Buccisano, F; Maurillo, L; Principe, Mid; Voso, Mt; Gurnari, C; Venditti, A
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up. The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry
2017 Mayer, Flavia; Faglioni, Laura; Agabiti, Nera; Fenu, Susanna; Buccisano, Francesco; Latagliata, Roberto; Ricci, Roberto; Aloe Spiriti, Maria Antonietta; Tatarelli, Caterina; Breccia, Massimo; Cimino, Giuseppe; Fianchi, Luana; Criscuolo, Marianna; Gumenyuk, Svitlana; Mancini, Stefano; Maurillo, Luca; Nobile, Carolina; Niscola, Pasquale; Piccioni, Anna Lina; Tafuri, Agostino; Trapã, Giulio; Andriani, Alessandro; De Fabritiis, Paolo; Voso, Maria Teresa; Davoli, Marina; Zini, Gina
A single center experience of unrelated umbilical cord blood transplant (Cbt) in childhood myelodisplastic syndromes (Mds)
2002 Picardi, A; Dentamaro, T; Cudillo, L; Postorino, M; Ballatore, G; Cupelli, L; Maurillo, L; Del Principe, D; Abruzzese, E; Panetta, P; De Fabritiis, P; Amadori, S
Acute Leukemia and Latent Tuberculosis Infection in Italy: Quantiferon-Tb Test Screening in a Low Tuberculosis Incidence Country T2 - MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
2024 Nunzi, A; Della Valle, L; Lindfors Rossi, El; Ranucci, G; Mallegni, F; Moretti, F; Meddi, E; Guarnera, L; Tiravanti, I; Taka, K; Buzzatti, E; Esposito, F; Secchi, R; Di Giuliano, F; Chirico, F; Palmieri, R; Maurillo, L; Buccisano, F; Gurnari, C; Paterno, G; Venditti, A; Del Principe, Mi.
Addition of rituximab to fludarabine improves progression free survival in untreated ZAP-70 negative chronic lymphocytic leukemia (CLL)
2004 Del Principe, Mi; Del Poeta, G; Maurillo, L; Venditti, A; Buccisano, F; Abruzzese, E; Consalvo, Mi; Piccioni, D; Gattei, V; Lo Coco, F; Amadori, S
Allogeneic stem cell transplantation is the optimal post-remission therapy in minimal residual disease positive patients with acute myeloid leukemia
2007 Gianni, L; Buccisano, F; Maurillo, L; Del Poeta, G; Del Principe, I; Ottaviani, I; Sarlo, C; Ammatuna, E; Campagna, S; Imo Consalvo, M; Amadori, S; Venditti, A
An altered Lecam1/ICAM1 ratio on CD34+cells predicts leukemic progression in MDS patients
2001 Buccisano, F; Venditti, A; Tamburini, A; Del Poeta, G; Maurillo, L; Abruzzese, E; Scornajenghi, Ka; Amadori, S
An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms
2015 Breccia, M; Voso, Mt; ALOE SPIRITI, Maria Antonietta; Fenu, S; Maurillo, L; Buccisano, F; Tafuri, Agostino; Alimena, Giuliana
Analysis of parameters influencing the positive selection of peripheral blood progenitor cells in patients with hematological malignancies and solid tumors
1998 Bruno, A; Adorno, G; Del Poeta, G; Venditti, A; Ballatore, G; Zinno, F; Lanti, A; Buccisano, F; Tamburini, A; Caravita, T; Santinelli, S; Maurillo, L; Aronica, G; Masi, M; Isacchi, G; Amadori, S
Autologous stem cell transplantation in patients with myeloproliferative diseases results in altered nerve growth factor levels
1999 Simone, Md; Maurillo, L; Triaca, V; De Santis, S; Postorino, M; Cudillo, L; Amadori, S; Aloe, L
Azacitidine for the treatment of lower risk myelodysplastic syndromes : a retrospective study of 74 patients enrolled in an Italian named patient program.
2010 Musto, P; Maurillo, L; Spagnoli, A; Gozzini, A; Rivellini, F; Lunghi, M; Villani, O; ALOE SPIRITI, Maria Antonietta; Venditti, A; Santini, V; AD HOC ITALIAN COOPERATIVE STUDY GROUP ON AZACITIDINE IN MYELODYSPLASTIC SYNDROMES ACUTE, Leukemias
Azacitidine for the treatment of lower risk myelodysplastic syndromes: final results from an Italian named patient program
2009 Musto, P; Maurillo, L; Spagnoli, A; D'Arco, A; Pollio, B; Candoni, A; Spiriti, A Aloe; Lunghi, M; Fili, C; Orciuolo, E; Venditti, A; Morabito, F; Mazza, P; Pastore, D; Santini, V
Azacitidine for the treatment of patients with acute myeloid leukemia : Report of 82 patients enrolled in an italian compassionate program
2010 Luca, Maurillo; Adriano, Venditti; Spagnoli, Alessandra; Gianluca, Gaidano; Dario, Ferrero; Esther, Oliva; Monia, Lunghi; Alfonso M., D'Arco; Alessandro, Levis; Domenico, Pastore; Nicola Di, Renzo; Alberto, Santagostino; Vincenzo, Pavone; Francesco, Buccisano; Pellegrino, Musto
Bax/Bcl-2 and P-glycoprotein modulate the prognostic impact of cytogenetics in acute myeloid leukemia (AML)
1999 Del Poeta, G; Venditti, A; Maurillo, L; Buccisano, F; Tamburini, A; Bruno, A; Cox, Mc; Battaalia, A; Epiceno, Am; Del Moro, B; Suppo, G; Del Principe, Mi; Amadori, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| - Evolution of transcriptomic profiles in relapsed inv(16) acute myeloid leukemia T2 - LEUKEMIA RESEARCH | 2024 | Travaglini, S; Silvestrini, G; Attardi, E; Fanciulli, M; Scalera, S; Antonelli, S; Maurillo, L; Palmieri, R; Divona, M; Ciuffreda, L; Savi, A; Paterno, G; Ottone, T; Barbieri, C; Maciejewski, Jp; Gurnari, C; Ciliberto, G; Voso, Mt | |
| - Is There a Better Therapeutic Time Window from Diagnosis to Treatment for Elderly Acute Myeloid Leukemia Patients Receiving Hypomethylating Agents? T2 - MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | 2024 | Molica, M; Maurillo, L; Rossi, M; Breccia, M; Mazzone, C; De Fabritiis, P; Perrone, S | |
| - Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial T2 - BLOOD ADVANCES CP - 49th National Congress of the Italian-Society-of-Hematology (SIE) | 2024 | Venditti, A; Piciocchi, A; Candoni, A; Arena, V; Palmieri, R; Filì, C; Carella, Am; Calafiore, V; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Curti, A; Luppi, M; Ingrosso, C; Martelli, Mp; Cuneo, A; Albano, F; Mulè, A; Tafuri, A; Cudillo, L; Tieghi, A; Fracchiolla, Ns; Capelli, D; Trisolini, Sm; Alati, C; La Sala, E; Maurillo, L; Del Principe, Mi; Irno Consalvo, Ma; Divona, Md; Ottone, T; Cerretti, R; Sconocchia, G; Voso, Mt; Fazi, P; Vignetti, M; Buccisano, F | |
| 5-AZACYTIDINE FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA: RESULTS IN 45 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM | 2008 | Musto, P; Maurillo, L; Spagnoli, A; Genuardi, M; Lunghi, M; Di Renzo, N; Mele, G; Levis, A; D'Arco, A; Gozzini, A; Petrini, M; Mianulli, M; Sanpaolo, G; Santagostino, A; Pietrantuono, G; D'Auria, E; Ferrero, D; Gaidano, G; Ferrara, E; Santini, V; Leone, G; Bosi, A; Venditti, A | |
| 5-AZACYTIDINE FOR THE TREATMENT OF INTERMEDIATE-2/HIGH IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS IN 83 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM | 2008 | Maurillo, L; Spagnoli, A; Gozzini, A; Cecconi, N; D'Argenio, M; Lunghi, M; Rocco, S; Palumbo, G; Rivellini, E; Genuardi, M; Sibilla, S; Ferrara, F; Mele, G; Filardi, N; Sanpaolo, G; Specchia, G; Tonso, A; Santagostino, A; Voso, M T; Balleari, E; Cassibba, V; Della Cioppa, P; Mazzone, C; Oliva, E; Ciuffreda, L; Russo, D; Galimberti, S; Villani, O; D'Auria, F; Di Renzo, N; D'Arco, A M | |
| <i>Pneumocystis jirovecii</i> pneumonia in patients with previously untreated acute myeloid leukaemia | 2022 | Paterno, G; Guarnera, L; Palmieri, R; Del Prete, V; Bonanni, F; Buzzatti, E; Moretti, F; Casciani, P; Savi, A; Di Cave, D; Maurillo, L; Buccisano, F; Venditti, A; Del Principe, Mi | |
| A complex clinical presentation of ultra-high risk acute promyelocytic leukemia: A case report and insights on management T2 - CURRENT RESEARCH IN TRANSLATIONAL MEDICINE | 2025 | De Marchi, L; Paterno, G; Taka, K; Giannì, L; Colafranceschi, G; Ottone, T; Rizzo, M; Divona, M; Palmieri, R; Buccisano, F; Maurillo, L; Principe, Mid; Voso, Mt; Gurnari, C; Venditti, A | |
| A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up. The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry | 2017 | Mayer, Flavia; Faglioni, Laura; Agabiti, Nera; Fenu, Susanna; Buccisano, Francesco; Latagliata, Roberto; Ricci, Roberto; Aloe Spiriti, Maria Antonietta; Tatarelli, Caterina; Breccia, Massimo; Cimino, Giuseppe; Fianchi, Luana; Criscuolo, Marianna; Gumenyuk, Svitlana; Mancini, Stefano; Maurillo, Luca; Nobile, Carolina; Niscola, Pasquale; Piccioni, Anna Lina; Tafuri, Agostino; Trapã, Giulio; Andriani, Alessandro; De Fabritiis, Paolo; Voso, Maria Teresa; Davoli, Marina; Zini, Gina | |
| A single center experience of unrelated umbilical cord blood transplant (Cbt) in childhood myelodisplastic syndromes (Mds) | 2002 | Picardi, A; Dentamaro, T; Cudillo, L; Postorino, M; Ballatore, G; Cupelli, L; Maurillo, L; Del Principe, D; Abruzzese, E; Panetta, P; De Fabritiis, P; Amadori, S | |
| Acute Leukemia and Latent Tuberculosis Infection in Italy: Quantiferon-Tb Test Screening in a Low Tuberculosis Incidence Country T2 - MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | 2024 | Nunzi, A; Della Valle, L; Lindfors Rossi, El; Ranucci, G; Mallegni, F; Moretti, F; Meddi, E; Guarnera, L; Tiravanti, I; Taka, K; Buzzatti, E; Esposito, F; Secchi, R; Di Giuliano, F; Chirico, F; Palmieri, R; Maurillo, L; Buccisano, F; Gurnari, C; Paterno, G; Venditti, A; Del Principe, Mi. | |
| Addition of rituximab to fludarabine improves progression free survival in untreated ZAP-70 negative chronic lymphocytic leukemia (CLL) | 2004 | Del Principe, Mi; Del Poeta, G; Maurillo, L; Venditti, A; Buccisano, F; Abruzzese, E; Consalvo, Mi; Piccioni, D; Gattei, V; Lo Coco, F; Amadori, S | |
| Allogeneic stem cell transplantation is the optimal post-remission therapy in minimal residual disease positive patients with acute myeloid leukemia | 2007 | Gianni, L; Buccisano, F; Maurillo, L; Del Poeta, G; Del Principe, I; Ottaviani, I; Sarlo, C; Ammatuna, E; Campagna, S; Imo Consalvo, M; Amadori, S; Venditti, A | |
| An altered Lecam1/ICAM1 ratio on CD34+cells predicts leukemic progression in MDS patients | 2001 | Buccisano, F; Venditti, A; Tamburini, A; Del Poeta, G; Maurillo, L; Abruzzese, E; Scornajenghi, Ka; Amadori, S | |
| An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms | 2015 | Breccia, M; Voso, Mt; ALOE SPIRITI, Maria Antonietta; Fenu, S; Maurillo, L; Buccisano, F; Tafuri, Agostino; Alimena, Giuliana | |
| Analysis of parameters influencing the positive selection of peripheral blood progenitor cells in patients with hematological malignancies and solid tumors | 1998 | Bruno, A; Adorno, G; Del Poeta, G; Venditti, A; Ballatore, G; Zinno, F; Lanti, A; Buccisano, F; Tamburini, A; Caravita, T; Santinelli, S; Maurillo, L; Aronica, G; Masi, M; Isacchi, G; Amadori, S | |
| Autologous stem cell transplantation in patients with myeloproliferative diseases results in altered nerve growth factor levels | 1999 | Simone, Md; Maurillo, L; Triaca, V; De Santis, S; Postorino, M; Cudillo, L; Amadori, S; Aloe, L | |
| Azacitidine for the treatment of lower risk myelodysplastic syndromes : a retrospective study of 74 patients enrolled in an Italian named patient program. | 2010 | Musto, P; Maurillo, L; Spagnoli, A; Gozzini, A; Rivellini, F; Lunghi, M; Villani, O; ALOE SPIRITI, Maria Antonietta; Venditti, A; Santini, V; AD HOC ITALIAN COOPERATIVE STUDY GROUP ON AZACITIDINE IN MYELODYSPLASTIC SYNDROMES ACUTE, Leukemias | |
| Azacitidine for the treatment of lower risk myelodysplastic syndromes: final results from an Italian named patient program | 2009 | Musto, P; Maurillo, L; Spagnoli, A; D'Arco, A; Pollio, B; Candoni, A; Spiriti, A Aloe; Lunghi, M; Fili, C; Orciuolo, E; Venditti, A; Morabito, F; Mazza, P; Pastore, D; Santini, V | |
| Azacitidine for the treatment of patients with acute myeloid leukemia : Report of 82 patients enrolled in an italian compassionate program | 2010 | Luca, Maurillo; Adriano, Venditti; Spagnoli, Alessandra; Gianluca, Gaidano; Dario, Ferrero; Esther, Oliva; Monia, Lunghi; Alfonso M., D'Arco; Alessandro, Levis; Domenico, Pastore; Nicola Di, Renzo; Alberto, Santagostino; Vincenzo, Pavone; Francesco, Buccisano; Pellegrino, Musto | |
| Bax/Bcl-2 and P-glycoprotein modulate the prognostic impact of cytogenetics in acute myeloid leukemia (AML) | 1999 | Del Poeta, G; Venditti, A; Maurillo, L; Buccisano, F; Tamburini, A; Bruno, A; Cox, Mc; Battaalia, A; Epiceno, Am; Del Moro, B; Suppo, G; Del Principe, Mi; Amadori, S |